16.7
속도 프로그램형 약물 전달 시스템, 또는 DDS는 일정한 치료 농도를 유지하기 위해 약물을 특정하고 제어된 속도로 방출하도록 설계됩니다. 이러한 시스템은 방출 기전에 따라 용해 제어형 DDS, 확산 제어형 DDS, 그리고 용해-확산 제어형 DDS로 분류됩니다.
용해 제…
속도 프로그래밍된 DDS는 고분자 매트릭스, 저장소, 삼투압 펌프, 마이크로칩 시스템과 같은 방식을 사용하여 통제된 속도로 약물을 방출합니다. 속도 프로그래밍 약물 전달 시스템에는 다양한 유형이 포함됩니다.
용해조절 DDS에서는 방출 속도가 약물 또는 주변 매트릭스의 느린 용해에 따라 달라집니다.
용해가 느린 약물은 점진적으로 용해되고, 다른 약물은 위장액과 접촉하면 더 느리게 녹는 형태로 변합니다.
또 다른 방법은 천천히 녹는 매트릭스에 약물을 삽입하거나 천천히 녹는 물질로 코팅하여 액체 침투를 제어하는 방법입니다.
확산 제어 DDS에서는 방출 속도가 분해되지 않고 수로 팽창하거나 불용하는 속도 조절 요소를 통해 용해된 약물 분자가 확산되는 현상에 따라 달라집니다.
잔탄검, HPMC, 에틸 셀룰로오스와 같은 고분자가 이러한 약물 전달 시스템에서 흔히 사용됩니다.
용해와 확산 제어 DDS는 용해와 확산을 통해 약물 방출 속도를 조절하는 재료를 사용하여 두 메커니즘을 결합합니다.
View the full transcript and gain access to JoVE Core videos
Q1: What are the main types of rate-programmed drug delivery systems?
Rate-programmed drug delivery systems include dissolution-controlled, diffusion-controlled, and combined dissolution-diffusion-controlled approaches. Dissolution-controlled systems rely on slow drug or matrix dissolution. Diffusion-controlled systems use non-degradable barriers that regulate drug diffusion. Combined systems integrate both mechanisms to achieve precise, sustained release and maintain consistent therapeutic levels.
Q2: How does dissolution control drug release in modified release systems?
In dissolution-controlled systems, release rate depends on how slowly the drug or surrounding matrix dissolves. Drugs with inherently slow dissolution rates, like griseofulvin and digoxin, dissolve gradually in gastrointestinal fluids. Some drugs transform into slower-dissolving forms upon contact with GI fluids, extending release. Embedding drugs in slowly dissolving matrices or coating them with slow-dissolving materials further regulates fluid penetration and delays drug release.
Q3: What role do polymers play in diffusion-controlled drug delivery?
Polymers form rate-controlling barriers that regulate drug diffusion without dissolving or degrading. Water-swellable polymers like xanthan gum, HPMC, and alginates absorb fluid while maintaining structural integrity. Water-insoluble polymers such as ethyl cellulose and polymethacrylates create stable diffusion barriers. These materials ensure steady, predictable drug release by controlling how dissolved drug molecules pass through the barrier.
Q4: How do combined dissolution-diffusion systems improve drug delivery control?
Combined dissolution-diffusion-controlled systems integrate slow-dissolving coatings with diffusion barriers to enhance release precision. By utilizing materials that influence both dissolution and diffusion processes simultaneously, these hybrid designs achieve superior control over drug release rates. This dual-mechanism approach provides flexible solutions for medications requiring prolonged absorption, improving patient compliance and treatment efficiency.
Q5: What is the difference between water-swellable and water-insoluble polymers in drug delivery?
Water-swellable polymers like xanthan gum and HPMC absorb gastrointestinal fluids while remaining structurally intact, allowing controlled drug diffusion through the swollen matrix. Water-insoluble polymers such as ethyl cellulose and polymethacrylates do not absorb fluid but form impermeable barriers that regulate drug passage. Both types maintain non-degradable, stable structures throughout drug delivery, ensuring predictable release kinetics.
Q6: Why are rate-programmed systems beneficial for patient compliance?
Rate-programmed systems maintain consistent therapeutic drug levels by releasing medication at controlled rates, reducing dosing frequency and improving patient compliance. By providing prolonged absorption and sustained therapeutic effects, these systems enhance treatment efficiency and reduce the burden of frequent medication administration. This controlled approach ensures better therapeutic outcomes while minimizing side effects associated with fluctuating drug concentrations.
Q7: How do drugs like ferrous sulfate behave differently in dissolution-controlled systems?
Ferrous sulfate transforms into a slower-dissolving form when exposed to gastrointestinal fluids, extending its release profile in dissolution-controlled systems. This chemical transformation upon contact with GI fluids naturally slows drug dissolution, allowing gradual absorption. Such drugs demonstrate how dissolution-controlled systems can exploit inherent drug properties to achieve sustained release without requiring additional matrix or coating materials.